RecruitingNot ApplicableNCT06720272

School-based Program for the Prevention of Rheumatic Heart Disease in Endemic Regions

Effectiveness of an Integrated Program for the Prevention of Rheumatic Heart Disease in Endemic Regions: a Stepped Wedge Cluster Randomized Trial


Sponsor

Thomas Pilgrim

Enrollment

6,000 participants

Start Date

Dec 15, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The overall objective of the PREVENT trial is to evaluate the effectiveness of an integrated, school-based program for the prevention of rheumatic heart disease (RHD) in regions with an endemic pattern of RHD. We conduct a stepped wedge cluster randomized trial in randomly selected schools in Nepal and Zambia. The intervention will be delivered at the level of the school and consists in the introduction of a dedicated school-nurse program providing health care through education about RHD, assessment, intervention, and follow-up of GABHS pharyngitis, and facilitation of secondary antibiotic prophylaxis for children with RHD.


Eligibility

Min Age: 5 YearsMax Age: 16 Years

Inclusion Criteria1

  • \- Children aged 5-16 years

Exclusion Criteria2

  • Children / primary caregivers not providing informed consent to participate
  • Children not attending one of the selected schools

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERSchool nurse program

The intervention consists in the introduction of a school-nurse program providing health care through education about rheumatic heart disease, assessment, intervention, and follow-up of group A beta-hemolytic streptococcal pharyngitis, and facilitation of secondary antibiotic prophylaxis for children with rheumatic heart disease.


Locations(2)

National Academy od Medical Sciences

Kathmandu, Nepal

Centre of Infectious Disease Research

Lusaka, Zambia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06720272